Trevi Therapeutics (TRVI) PT Raised to $20 at Rodman & Renshaw
Tweet Send to a Friend
Rodman & Renshaw analyst Brandon Folkes raised the price target on Trevi Therapeutics (NASDAQ: TRVI) to $20.00 (from $7.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
